From Osteoimmunology to Osteomicrobiology: How the Microbiota and the Immune System Regulate Bone

Review

Abstract

Osteomicrobiology refers to the role of microbiota in bone health and the mechanisms by which the microbiota regulates post-natal skeletal development, bone aging, and pathologic bone loss. Here, we review recent reports linking gut microbiota to changes in bone phenotype. A pro-inflammatory cytokine milieu drives bone resorption in conditions such as sex steroid hormone deficiency. The response of the immune system to activation by the microbiome results in increased circulating osteoclastogenic cytokines in a T cell-dependent mechanism. Additionally, gut microbiota affect bone homeostasis through nutrient absorption, mediation of the IGF-1 pathway, and short chain fatty acid and metabolic products. Manipulation of microbiota through prebiotics or probiotics reduces inflammatory cytokine production, leading to changes in bone density. One mechanism of probiotic action is through upregulating tight junction proteins, increasing the strength of the gut epithelial layer, and leading to less antigen presentation and less activation of intestinal immune cells. Thus, prebiotics or probiotics may represent a future therapeutic avenue for ameliorating the risk of postmenopausal bone loss in humans.

Keywords

Estrogen Sex steroids Microbiota Intestine Bone loss Probiotics LGG VSL#3™ 

Abbreviations

BM

Bone marrow

GF

Germ-Free

Conv.R

Conventionally raised

TNF

Tumor necrosis factor α

References

  1. 1.
    Lin PW, Myers LE, Ray L, Song SC, Nasr TR, Berardinelli AJ, Kundu K, Murthy N, Hansen JM, Neish AS (2009) Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med 47:1205–1211PubMedPubMedCentralCrossRefGoogle Scholar
  2. 2.
    Sommer F, Backhed F (2013) The gut microbiota–masters of host development and physiology. Nat Rev Microbiol 11:227–238PubMedCrossRefGoogle Scholar
  3. 3.
    Tremaroli V, Backhed F (2012) Functional interactions between the gut microbiota and host metabolism. Nature 489:242–249PubMedCrossRefGoogle Scholar
  4. 4.
    Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498PubMedPubMedCentralCrossRefGoogle Scholar
  5. 5.
    Josefsdottir KS, Baldridge MT, Kadmon CS, King KY (2017) Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota. Blood 129:729–739PubMedCrossRefGoogle Scholar
  6. 6.
    Erny D, Hrabe de Angelis AL, Prinz M (2017) Communicating systems in the body: how microbiota and microglia cooperate. Immunology 150:7–15PubMedCrossRefGoogle Scholar
  7. 7.
    Emal D, Rampanelli E, Stroo I, Butter LM, Teske GJ, Claessen N, Stokman G, Florquin S, Leemans JC, Dessing MC (2017) Depletion of gut microbiota protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 28:1450–1461PubMedCrossRefGoogle Scholar
  8. 8.
    Wang J, Qi J, Zhao H, He S, Zhang Y, Wei S, Zhao F (2013) Metagenomic sequencing reveals microbiota and its functional potential associated with periodontal disease. Sci Rep 3:1843PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Varelias A, Ormerod KL, Bunting MD, Koyama M, Gartlan KH, Kuns RD, Lachner N, Locke KR, Lim CY, Henden AS, Zhang P, Clouston AD, Hasnain SZ, McGuckin MA, Blazar BR, MacDonald KP, Hugenholtz P, Hill GR (2017) Acute graft-versus-host disease is regulated by an IL-17-sensitive microbiome. Blood 129:2172–2185PubMedCrossRefGoogle Scholar
  10. 10.
    Ohlsson C, Sjogren K (2014) Effects of the gut microbiota on bone mass. Trends Endocrinol Metab 26:69–74PubMedCrossRefGoogle Scholar
  11. 11.
    Zaidi M (2007) Skeletal remodeling in health and disease. Nat Med 13:791–801PubMedCrossRefGoogle Scholar
  12. 12.
    Pacifici R, Rifas L, Teitelbaum S, Slatopolsky E, McCracken R, Bergfeld M, Lee W, Avioli LV, Peck WA (1987) Spontaneous release of interleukin 1 from human blood monocytes reflects bone formation in idiopathic osteoporosis. Proc Natl Acad Sci U S A 84:4616–4620PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Redlich K, Smolen JS (2012) Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 11:234–250PubMedCrossRefGoogle Scholar
  14. 14.
    Mbalaviele G, Novack DV, Schett G, Teitelbaum SL (2017) Inflammatory osteolysis: a conspiracy against bone. J Clin Invest 127:2030–2039PubMedCrossRefGoogle Scholar
  15. 15.
    Khosla S, Pacifici R (2013) Estrogen deficiency, Postmenopausal osteoporosis, and Age-related bone loss. In: Marcus R, Feldman D, Dempster DW, Luckey M, Cauley JA (eds) Osteoporosis. Elsvierer, Amsterdam, pp 1113–1138CrossRefGoogle Scholar
  16. 16.
    Weitzmann MN, Pacifici R (2006) Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest 116:1186–1194PubMedPubMedCentralCrossRefGoogle Scholar
  17. 17.
    Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, Zaidi S, Zhu LL, Yaroslavskiy BB, Zhou H, Zallone A, Sairam MR, Kumar TR, Bo W, Braun J, Cardoso-Landa L, Schaffler MB, Moonga BS, Blair HC, Zaidi M (2006) FSH directly regulates bone mass. Cell 125:247–260PubMedCrossRefGoogle Scholar
  18. 18.
    Nakamura T, Imai Y, Matsumoto T, Sato S, Takeuchi K, Igarashi K, Harada Y, Azuma Y, Krust A, Yamamoto Y, Nishina H, Takeda S, Takayanagi H, Metzger D, Kanno J, Takaoka K, Martin TJ, Chambon P, Kato S (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130:811–823PubMedCrossRefGoogle Scholar
  19. 19.
    Krum SA, Miranda-Carboni GA, Hauschka PV, Carroll JS, Lane TF, Freedman LP, Brown M (2008) Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J 27:535–545PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA (1989) Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A 86:2398–2402PubMedPubMedCentralCrossRefGoogle Scholar
  21. 21.
    Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, McCracken R, Avioli LV (1991) Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci U S A 88:5134–5138PubMedPubMedCentralCrossRefGoogle Scholar
  22. 22.
    Cohen-Solal ME, Graulet AM, Denne MA, Gueris J, Baylink D, de Vernejoul MC (1993) Peripheral monocyte culture supernatants of menopausal women can induce bone resorption: involvement of cytokines. J Clin Endocrinol Metab 77:1648–1653PubMedGoogle Scholar
  23. 23.
    Beaudreuil J, Mbalaviele G, Cohen-Solal M, Morieux C, de Vernejoul MC, Orcel P (1995) Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats. J Bone Miner Res 10:971–977PubMedCrossRefGoogle Scholar
  24. 24.
    Bernard-Poenaru O, Roux C, Blanque R, Gardner C, de Vemejoul MC, Cohen-Solal ME (2001) Bone-resorbing cytokines from peripheral blood mononuclear cells after hormone replacement therapy: a longitudinal study. Osteoporos Int 12:769–776PubMedCrossRefGoogle Scholar
  25. 25.
    Charatcharoenwitthaya N, Khosla S, Atkinson EJ, McCready LK, Riggs BL (2007) Effect of blockade of tumor necrosis factor-alpha and interleukin-1 action on bone resorption in early postmenopausal women. J Bone Miner Res 22:724–729PubMedCrossRefGoogle Scholar
  26. 26.
    Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R (2001) Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA 98:13960–13965PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Ammann P, Rizzoli R, Bonjour JP, Bourrin S, Meyer JM, Vassalli P, Garcia I (1997) Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest 99:1699–1703PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Kimble RB, Bain S, Pacifici R (1997) The functional block of TNF but not of IL-6 prevents bone loss in ovariectomized mice. J Bone Miner Res 12:935–941PubMedCrossRefGoogle Scholar
  29. 29.
    Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R (2000) Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106:1229–1237PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Lam J, Takeshita S, Barker JE, Kanagawa O, Ross FP, Teitelbaum SL (2000) TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand. J Clin Invest 106:1481–1488PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Nakae S, Suto H, Berry GJ, Galli SJ (2007) Mast cell-derived TNF can promote Th17 cell-dependent neutrophil recruitment in ovalbumin-challenged OTII mice. Blood 109:3640–3648PubMedPubMedCentralCrossRefGoogle Scholar
  32. 32.
    Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL (2011) Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Res Ther 13:R126PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Sugita S, Kawazoe Y, Imai A, Yamada Y, Horie S, Mochizuki M (2012) Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behcet’s disease. Arthritis Res Ther 14:R99PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Xiong J, Onal M, Jilka RL, Weinstein RS, Manolagas SC, O’Brien CA (2011) Matrix-embedded cells control osteoclast formation. Nat Med 17:1235–1241PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Nakashima T, Hayashi M, Fukunaga T, Kurata K, Oh-Hora M, Feng JQ, Bonewald LF, Kodama T, Wutz A, Wagner EF, Penninger JM, Takayanagi H (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat Med 17:1231–1234PubMedCrossRefGoogle Scholar
  36. 36.
    D’Amelio P, Grimaldi A, Di Bella S, Brianza SZ, Cristofaro MA, Tamone C, Giribaldi G, Ulliers D, Pescarmona GP, Isaia G (2008) Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. Bone 43:92–100PubMedCrossRefGoogle Scholar
  37. 37.
    Adeel S, Singh K, Vydareny KH, Kumari M, Shah E, Weitzmann MN, Tangpricha V (2013) Bone loss in surgically ovariectomized premenopausal women is associated with T lymphocyte activation and thymic hypertrophy. J Investig Med 61:1178–1183PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Gao Y, Qian WP, Dark K, Toraldo G, Lin AS, Guldberg RE, Flavell RA, Weitzmann MN, Pacifici R (2004) Estrogen prevents bone loss through transforming growth factor beta signaling in T cells. Proc Natl Acad Sci USA 101:16618–16623PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Gao Y, Grassi F, Ryan MR, Terauchi M, Page K, Yang X, Weitzmann MN, Pacifici R (2007) IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 117:122–132PubMedCrossRefGoogle Scholar
  40. 40.
    Li JY, Tawfeek H, Bedi B, Yang X, Adams J, Gao KY, Zayzafoon M, Weitzmann MN, Pacifici R (2011) Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci USA 108:768–773PubMedCrossRefGoogle Scholar
  41. 41.
    Grassi F, Tell G, Robbie-Ryan M, Gao Y, Terauchi M, Yang X, Romanello M, Jones DP, Weitzmann MN, Pacifici R (2007) Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA 104:15087–15092PubMedPubMedCentralCrossRefGoogle Scholar
  42. 42.
    Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W, Patel V, Gutkind S, Young M, Gronthos S, Le A, Wang CY, Chen W, Shi S (2008) Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS ONE 3:e2615PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    Tyagi AM, Srivastava K, Kureel J, Kumar A, Raghuvanshi A, Yadav D, Maurya R, Goel A, Singh D (2012) Premature T cell senescence in Ovx mice is inhibited by repletion of estrogen and medicarpin: a possible mechanism for alleviating bone loss. Osteoporos Int 23:1151–1161PubMedCrossRefGoogle Scholar
  44. 44.
    Molnar I, Bohaty I, Somogyine-Vari E (2014) IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis. Osteoporos Int 25:783–786PubMedCrossRefGoogle Scholar
  45. 45.
    Zhang J, Fu Q, Ren Z, Wang Y, Wang C, Shen T, Wang G, Wu L (2014) Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis. Gynecol Endocrinol 31:183–190PubMedCrossRefGoogle Scholar
  46. 46.
    Molnar I, Bohaty I, Somogyine-Vari E (2014) High prevalence of increased interleukin-17A serum levels in postmenopausal estrogen deficiency. Menopause 21:749–752PubMedCrossRefGoogle Scholar
  47. 47.
    Tyagi AM, Srivastava K, Mansoori MN, Trivedi R, Chattopadhyay N, Singh D (2012) Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis. PLoS ONE 7:e44552PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Basu R, Hatton RD, Weaver CT (2013) The Th17 family: flexibility follows function. Immunol Rev 252:89–103PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179–189PubMedCrossRefGoogle Scholar
  50. 50.
    DeSelm CJ, Takahata Y, Warren J, Chappel JC, Khan T, Li X, Liu C, Choi Y, Kim YF, Zou W, Teitelbaum SL (2012) IL-17 mediates estrogen-deficient osteoporosis in an Act1-dependent manner. J Cell Biochem 113:2895–2902PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Tyagi AM, Mansoori MN, Srivastava K, Khan MP, Kureel J, Dixit M, Shukla P, Trivedi R, Chattopadhyay N, Singh D (2014) Enhanced immunoprotective effects by anti-IL-17 antibody translates to improved skeletal parameters under estrogen deficiency compared with anti-RANKL and anti-TNF-alpha antibodies. J Bone Miner Res 29:1981–1992PubMedCrossRefGoogle Scholar
  52. 52.
    Shevach EM (2009) Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30:636–645PubMedCrossRefGoogle Scholar
  53. 53.
    Zaiss MM, Axmann R, Zwerina J, Polzer K, Guckel E, Skapenko A, Schulze-Koops H, Horwood N, Cope A, Schett G (2007) Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum 56:4104–4112PubMedCrossRefGoogle Scholar
  54. 54.
    Kim YG, Lee CK, Nah SS, Mun SH, Yoo B, Moon HB (2007) Human CD4+ CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun 357:1046–1052PubMedCrossRefGoogle Scholar
  55. 55.
    Kelchtermans H, Geboes L, Mitera T, Huskens D, Leclercq G, Matthys P (2009) Activated CD4+ CD25+ regulatory T cells inhibit osteoclastogenesis and collagen-induced arthritis. Ann Rheum Dis 68:744–750PubMedCrossRefGoogle Scholar
  56. 56.
    Luo CY, Wang L, Sun C, Li DJ (2011) Estrogen enhances the functions of CD4(+)CD25(+)Foxp3(+) regulatory T cells that suppress osteoclast differentiation and bone resorption in vitro. Cell Mol Immunol 8:50–58PubMedCrossRefGoogle Scholar
  57. 57.
    Yuan FL, Li X, Lu WG, Xu RS, Zhao YQ, Li CW, Li JP, Chen FH (2010) Regulatory T cells as a potent target for controlling bone loss. Biochem Biophys Res Commun 402:173–176PubMedCrossRefGoogle Scholar
  58. 58.
    Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, Zhao L, An X, Du X, Chen X, Wang S, Xia G, Wang B (2008) Induction of regulatory T cells by physiological level estrogen. J Cell Physiol 214:456–464PubMedCrossRefGoogle Scholar
  59. 59.
    Zaiss MM, Sarter K, Hess A, Engelke K, Bohm C, Nimmerjahn F, Voll R, Schett G, David JP (2010) Increased bone density and resistance to ovariectomy-induced bone loss in FoxP3-transgenic mice based on impaired osteoclast differentiation. Arthritis Rheum 62:2328–2338PubMedCrossRefGoogle Scholar
  60. 60.
    Cho I, Yamanishi S, Cox L, Methe BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, Li H, Alekseyenko AV, Blaser MJ (2012) Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488:621–626PubMedPubMedCentralCrossRefGoogle Scholar
  61. 61.
    Schwarzer M, Makki K, Storelli G, Machuca-Gayet I, Srutkova D, Hermanova P, Martino ME, Balmand S, Hudcovic T, Heddi A, Rieusset J, Kozakova H, Vidal H, Leulier F (2016) Lactobacillus plantarum strain maintains growth of infant mice during chronic undernutrition. Science 351:854–857PubMedCrossRefGoogle Scholar
  62. 62.
    Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, von Bergen M, McCoy KD, Macpherson AJ, Danska JS (2013) Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 339:1084–1088PubMedCrossRefGoogle Scholar
  63. 63.
    Charles JF, Ermann J, Aliprantis AO (2015) The intestinal microbiome and skeletal fitness: connecting bugs and bones. Clin Immunol 159:163–169PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Yano JM, Yu K, Donaldson GP, Shastri GG, Ann P, Ma L, Nagler CR, Ismagilov RF, Mazmanian SK, Hsiao EY (2015) Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161:264–276PubMedPubMedCentralCrossRefGoogle Scholar
  65. 65.
    Sjogren K, Engdahl C, Henning P, Lerner UH, Tremaroli V, Lagerquist MK, Backhed F, Ohlsson C (2012) The gut microbiota regulates bone mass in mice. J Bone Miner Res 27:1357–1367PubMedPubMedCentralCrossRefGoogle Scholar
  66. 66.
    Li JY, Chassaing B, Tyagi AM, Vaccaro C, Luo T, Adams J, Darby TM, Weitzmann MN, Mulle JG, Gewirtz AT, Jones RM, Pacifici R (2016) Sex steroid deficiency-associated bone loss is microbiota dependent and prevented by probiotics. J Clin Invest 126:2049–2063PubMedPubMedCentralCrossRefGoogle Scholar
  67. 67.
    Novince CM, Whittow CR, Aartun JD, Hathaway JD, Poulides N, Chavez MB, Steinkamp HM, Kirkwood KA, Huang E, Westwater C, Kirkwood KL (2017) Commensal gut microbiota immunomodulatory actions in bone marrow and liver have catabolic effects on skeletal homeostasis in health. Sci Rep 7:5747PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Ohlsson C, Nigro G, Boneca IG, Backhed F, Sansonetti P, Sjogren K (2017) Regulation of bone mass by the gut microbiota is dependent on NOD1 and NOD2 signaling. Cell Immunol 317:55–58PubMedCrossRefGoogle Scholar
  69. 69.
    Yan J, Herzog JW, Tsang K, Brennan CA, Bower MA, Garrett WS, Sartor BR, Aliprantis AO, Charles JF (2016) Gut microbiota induce IGF-1 and promote bone formation and growth. Proc Natl Acad Sci USA 113:E7554–E7563PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Blanton LV, Charbonneau MR, Salih T, Barratt MJ, Venkatesh S, Ilkaveya O, Subramanian S, Manary MJ, Trehan I, Jorgensen JM, Fan YM, Henrissat B, Leyn SA, Rodionov DA, Osterman AL, Maleta KM, Newgard CB, Ashorn P, Dewey KG, Gordon JI (2016) Gut bacteria that prevent growth impairments transmitted by microbiota from malnourished children. Science 351:aad3311PubMedCrossRefGoogle Scholar
  71. 71.
    Charbonneau MR, O’Donnell D, Blanton LV, Totten SM, Davis JC, Barratt MJ, Cheng J, Guruge J, Talcott M, Bain JR, Muehlbauer MJ, Ilkayeva O, Wu C, Struckmeyer T, Barile D, Mangani C, Jorgensen J, Fan YM, Maleta K, Dewey KG, Ashorn P, Newgard CB, Lebrilla C, Mills DA, Gordon JI (2016) Sialylated milk oligosaccharides promote microbiota-dependent growth in models of infant undernutrition. Cell 164:859–871PubMedPubMedCentralCrossRefGoogle Scholar
  72. 72.
    Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, Kim SG, Li H, Gao Z, Mahana D, Zarate Rodriguez JG, Rogers AB, Robine N, Loke P, Blaser MJ (2014) Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 158:705–721PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Williams S, Wakisaka A, Zeng QQ, Barnes J, Martin G, Wechter WJ, Liang CT (1996) Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats. Bone 19:637–644PubMedCrossRefGoogle Scholar
  74. 74.
    Nobel YR, Cox LM, Kirigin FF, Bokulich NA, Yamanishi S, Teitler I, Chung J, Sohn J, Barber CM, Goldfarb DS, Raju K, Abubucker S, Zhou Y, Ruiz VE, Li H, Mitreva M, Alekseyenko AV, Weinstock GM, Sodergren E, Blaser MJ (2015) Metabolic and metagenomic outcomes from early-life pulsed antibiotic treatment. Nat Commun 6:7486PubMedPubMedCentralCrossRefGoogle Scholar
  75. 75.
    Stappenbeck TS, Virgin HW (2016) Accounting for reciprocal host-microbiome interactions in experimental science. Nature 534:191–199PubMedCrossRefGoogle Scholar
  76. 76.
    Ericsson AC, Davis JW, Spollen W, Bivens N, Givan S, Hagan CE, McIntosh M, Franklin CL (2015) Effects of vendor and genetic background on the composition of the fecal microbiota of inbred mice. PLoS ONE 10:e0116704PubMedPubMedCentralCrossRefGoogle Scholar
  77. 77.
    Laukens D, Brinkman BM, Raes J, De Vos M, Vandenabeele P (2016) Heterogeneity of the gut microbiome in mice: guidelines for optimizing experimental design. FEMS Microbiol Rev 40:117–132PubMedCrossRefGoogle Scholar
  78. 78.
    Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF Jr (1987) Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Ann Intern Med 106:354–361PubMedCrossRefGoogle Scholar
  79. 79.
    Finkelstein JS, Lee H, Leder BZ, Burnett-Bowie SA, Goldstein DW, Hahn CW, Hirsch SC, Linker A, Perros N, Servais AB, Taylor AP, Webb ML, Youngner JM, Yu EW (2016) Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J Clin Invest 126:1114–1125PubMedPubMedCentralCrossRefGoogle Scholar
  80. 80.
    Bilezikian JP, Morishima A, Bell J, Grumbach MM (1998) Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med 339:599–603PubMedCrossRefGoogle Scholar
  81. 81.
    Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES (2006) Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab 91:3908–3915PubMedCrossRefGoogle Scholar
  82. 82.
    O’Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC (1998) Microbiology of bacterial translocation in humans. Gut 42:29–35PubMedPubMedCentralCrossRefGoogle Scholar
  83. 83.
    Lunz JG 3rd, Specht SM, Murase N, Isse K, Demetris AJ (2007) Gut-derived commensal bacterial products inhibit liver dendritic cell maturation by stimulating hepatic interleukin-6/signal transducer and activator of transcription 3 activity. Hepatology 46:1946–1959PubMedCrossRefGoogle Scholar
  84. 84.
    McDole JR, Wheeler LW, McDonald KG, Wang B, Konjufca V, Knoop KA, Newberry RD, Miller MJ (2012) Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine. Nature 483:345–349PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Fasano A (2012) Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol 42:71–78PubMedCrossRefGoogle Scholar
  86. 86.
    Heyman M, Abed J, Lebreton C, Cerf-Bensussan N (2012) Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut 61:1355–1364PubMedCrossRefGoogle Scholar
  87. 87.
    Hijazi Z, Molla AM, Al-Habashi H, Muawad WMRA, Molla AM, Sharma PN (2004) Intestinal permeability is increased in bronchial asthma. Arch Dis Child 89:227–229PubMedPubMedCentralCrossRefGoogle Scholar
  88. 88.
    Teixeira TFS, Collado MC, Ferreira CLLF, Bressan J, Peluzio MDG (2012) Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr Res 32:637–647PubMedCrossRefGoogle Scholar
  89. 89.
    Raehtz S, Fedorko A, McCabe L (2014) Estrogen deficiency induced intestinal inflammation and permeability is linked with osteoporosis (488.8). FASEB J 28:488Google Scholar
  90. 90.
    Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, Kroesen AJ, Zeitz M, Fromm M, Schulzke JD (2007) Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut 56:61–72PubMedCrossRefGoogle Scholar
  91. 91.
    Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141:769–776PubMedCrossRefGoogle Scholar
  92. 92.
    Salminen S, Ouwehand A, Benno Y, Lee YK (1999) Probiotics: how should they be defined? Trends Food Sci Technol 10:107–110CrossRefGoogle Scholar
  93. 93.
    Narva M, Collin M, Lamberg-Allardt C, Karkkainen M, Poussa T, Vapaatalo H, Korpela R (2004) Effects of long-term intervention with lactobacillus helveticus-fermented milk on bone mineral density and bone mineral content in growing rats. Ann Nutr Metab 48:228–234PubMedCrossRefGoogle Scholar
  94. 94.
    Ohlsson C, Engdahl C, Fak F, Andersson A, Windahl SH, Farman HH, Moverare-Skrtic S, Islander U, Sjogren K (2014) Probiotics protect mice from ovariectomy-induced cortical bone loss. PLoS ONE 9:e92368PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Britton RA, Irwin R, Quach D, Schaefer L, Zhang J, Lee T, Parameswaran N, McCabe LR (2014) Probiotic L. reuteri treatment prevents bone loss in a menopausal ovariectomized mouse model. J Cell Physiol 229:1822–1830PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    McCabe LR, Irwin R, Schaefer L, Britton RA (2013) Probiotic use decreases intestinal inflammation and increases bone density in healthy male but not female mice. J Cell Physiol 228:1793–1798PubMedPubMedCentralCrossRefGoogle Scholar
  97. 97.
    Collins FL, Irwin R, Bierhalter H, Schepper J, Britton RA, Parameswaran N, McCabe LR (2016) Lactobacillus reuteri 6475 increases bone density in intact females only under an inflammatory setting. PLoS ONE 11:e0153180PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Jafarnejad S, Djafarian K, Fazeli MR, Yekaninejad MS, Rostamian A, Keshavarz SA (2017) Effects of a multispecies probiotic supplement on bone health in osteopenic postmenopausal women: a randomized, double-blind, controlled trial. J Am Coll Nutr 19:1–10Google Scholar
  99. 99.
    Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfroid MB (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17:259–275PubMedCrossRefGoogle Scholar
  100. 100.
    McCabe L, Britton RA, Parameswaran N (2015) Prebiotic and probiotic regulation of bone health: role of the Intestine and its Microbiome. Curr Osteoporos Rep 13:363–371PubMedPubMedCentralCrossRefGoogle Scholar
  101. 101.
    Weaver CM, Martin BR, Story JA, Hutchinson I, Sanders L (2010) Novel fibers increase bone calcium content and strength beyond efficiency of large intestine fermentation. J Agric Food Chem 58:8952–8957PubMedCrossRefGoogle Scholar
  102. 102.
    Legette LL, Lee W, Martin BR, Story JA, Campbell JK, Weaver CM (2012) Prebiotics enhance magnesium absorption and inulin-based fibers exert chronic effects on calcium utilization in a postmenopausal rodent model. J Food Sci 77:H88–H94PubMedCrossRefGoogle Scholar
  103. 103.
    Griffin IJ, Davila PM, Abrams SA (2002) Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br J Nutr 87(Suppl 2):S187–S191PubMedCrossRefGoogle Scholar
  104. 104.
    Abrams SA, Griffin IJ, Hawthorne KM, Liang L, Gunn SK, Darlington G, Ellis KJ (2005) A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr 82:471–476PubMedGoogle Scholar
  105. 105.
    Zafar TA, Weaver CM, Zhao Y, Martin BR, Wastney ME (2004) Nondigestible oligosaccharides increase calcium absorption and suppress bone resorption in ovariectomized rats. J Nutr 134:399–402PubMedGoogle Scholar
  106. 106.
    van den Heuvel EG, Schoterman MH, Muijs T (2000) Transgalactooligosaccharides stimulate calcium absorption in postmenopausal women. J Nutr 130:2938–2942PubMedGoogle Scholar
  107. 107.
    Garcia-Vieyra MI, Del Real A, Lopez MG (2014) Agave fructans: their effect on mineral absorption and bone mineral content. J Med Food 17:1247–1255PubMedCrossRefGoogle Scholar
  108. 108.
    Roberfroid MB, Cumps J, Devogelaer JP (2002) Dietary chicory inulin increases whole-body bone mineral density in growing male rats. J Nutr 132:3599–3602PubMedGoogle Scholar
  109. 109.
    Takahara S, Morohashi T, Sano T, Ohta A, Yamada S, Sasa R (2000) Fructooligosaccharide consumption enhances femoral bone volume and mineral concentrations in rats. J Nutr 130:1792–1795PubMedGoogle Scholar
  110. 110.
    Chonan O, Matsumoto K, Watanuki M (1995) Effect of galactooligosaccharides on calcium absorption and preventing bone loss in ovariectomized rats. Biosci Biotechnol Biochem 59:236–239PubMedCrossRefGoogle Scholar
  111. 111.
    Slevin MM, Allsopp PJ, Magee PJ, Bonham MP, Naughton VR, Strain JJ, Duffy ME, Wallace JM, Mc Sorley EM (2014) Supplementation with calcium and short-chain fructo-oligosaccharides affects markers of bone turnover but not bone mineral density in postmenopausal women. J Nutr 144:297–304PubMedCrossRefGoogle Scholar
  112. 112.
    Weaver CM (2015) Diet, gut microbiome, and bone health. Curr Osteoporos Rep 13:125–130PubMedPubMedCentralCrossRefGoogle Scholar
  113. 113.
    Donohoe DR, Garge N, Zhang X, Sun W, O’Connell TM, Bunger MK, Bultman SJ (2011) The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 13:517–526PubMedPubMedCentralCrossRefGoogle Scholar
  114. 114.
    Rowan S, Jiang S, Korem T, Szymanski J, Chang ML, Szelog J, Cassalman C, Dasuri K, McGuire C, Nagai R, Du XL, Brownlee M, Rabbani N, Thornalley PJ, Baleja JD, Deik AA, Pierce KA, Scott JM, Clish CB, Smith DE, Weinberger A, Avnit-Sagi T, Lotan-Pompan M, Segal E, Taylor A (2017) Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration. Proc Natl Acad Sci USA 114:E4472–E4481PubMedCrossRefGoogle Scholar
  115. 115.
    Lynch SV, Pedersen O (2016) The human intestinal microbiome in health and disease. N Engl J Med 375:2369–2379PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  1. 1.Division of Endocrinology, Metabolism and Lipids, Department of MedicineEmory UniversityAtlantaUSA
  2. 2.Immunology and Molecular Pathogenesis ProgramEmory UniversityAtlantaUSA

Personalised recommendations